Related by context. Frequent words. (Click for all words.) 58 Abstract Number 57 #:#-# [031] 57 Lenalidomide 56 Targeted Therapy 56 Factor VIIa 54 TLR9 agonist 54 Preclinical Data 54 Initiate Phase 54 #:#-# [006] 54 liposomal formulation 53 Initiates Phase II 53 Irinotecan 53 #:#-# [033] 53 Suppl 53 Polymorphism 53 Monoclonal Antibody 52 relapsing multiple sclerosis 52 J Nutr 52 #:#-# [035] 52 J Biol Chem 52 Idiopathic Pulmonary Fibrosis 52 murine model 52 Int J 52 Tacrolimus 52 sipuleucel T 52 polymerase inhibitor 52 poly ADP ribose polymerase 52 selective inhibitor 52 Recombinant Human 52 Clin 51 Dasatinib 51 colorectal carcinoma 51 Cancer Res 51 selective inhibition 51 refractory chronic lymphocytic 51 Protease 51 Commences Phase 51 selectively inhibits 51 Thrombin 51 Pivotal Phase III 51 bendamustine 51 #:#-# [023] 51 Initiates Phase 50 Cyclophosphamide 50 Phase Ib II 50 Immunol 50 trastuzumab Herceptin 50 Phase Ib clinical 50 MAb 50 CCX# 50 xenograft 50 Oligonucleotide 50 FLT3 50 Denufosol 50 VKORC1 50 pertuzumab 50 Inhibitors 50 Autoimmune Diseases 50 Metastatic Melanoma 50 gastrointestinal stromal tumors GIST 50 Exemestane 50 histone deacetylase 50 Analogs 49 glatiramer acetate 49 Belatacept 49 Ligands 49 humanized antibody 49 Oral Presentation 49 Solid Tumors 49 proteasome inhibitor 49 sunitinib malate 49 RNA Interference 49 Bortezomib 49 PARP inhibitor 49 Antisense 49 Patient Registry 49 bleomycin 49 BMS # 49 Hepatocellular Carcinoma 49 Cancer Vaccines 49 Biol 49 Oncol 49 Pediatr 49 Small Molecule 49 fluvastatin 49 Inflammatory Diseases 49 Daclizumab 49 mTOR inhibitor 49 PRIALT 49 Myelofibrosis 48 Neuropsychiatric 48 Temozolomide 48 Article PubMed ChemPort 48 TACE 48 mCRC patients 48 Pivotal Phase 48 BAL# [001] 48 Resp 48 Physiol 48 Nucleic Acid 48 Inhibitor